Results 51 to 60 of about 139,249 (224)

Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation

, 2004
Transplantation of hepatic grafts from ABO-incompatible donors is controversial because of the risk of hyperacute rejection mediated by preformed anti-ABO antibodies. The aim of the present study was to evaluate the outcome of liver transplants performed
Tanaka, Koichi, Oike, Fumitaka, Shapiro, A M James, Kaihara, Satoshi, Uryuhara, Kenji, Minamiguchi, Sachiko, Haga, Hironori, Egawa, Hiroto, Buehler, Leo Hans, Kiuchi, Tetsuya   +9 more
core   +1 more source

Heterogeneous effects of donor‐related risk factors in 954 pediatric liver transplantations

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Accepting a suitable donor for a child awaiting pediatric liver transplantation (pLT) is increasingly challenging. Donor‐specific risk factors influence post‐transplant outcomes, but evidence in pediatric patients remains inconsistent.
Christoph Leiskau, Norman Junge, Tobias Laue, Imeke Goldschmidt, Frauke E. Mutschler, Moritz Schmelzle, Nicolas Richter, Philipp Felgendreff, Cornelius J. van Beekum, Florian W. R. Vondran, Clara A. Weigle, Eva‐D. Pfister, Ulrich Baumann   +12 more
wiley   +1 more source

Isoagglutinin apheresis for ABO-incompatible renal transplantation

, 2011
Blood group antigens of the ABO-type are expressed with broad tissue distribution, including endothelial, epithelial and red blood cells. This has traditionally restricted solid organ transplantation to major ABO compatibility.
Black, A., Schmitz, Gerd, Dullinger, K., Ahrens, Norbert, Mack, M.   +4 more
core   +1 more source

ABO-incompatible living-donor lobar lung transplantation. [PDF]

, 2011
ABO-incompatible living-donor lobar lung transplantation was performed in a 10-year-old boy with bronchiolitis obliterans (BO) after bone marrow transplantation (BMT) for recurrent acute myeloid leukemia (AML).
Takuji Fujinaga, Tsuyoshi Shoji, Kimiko Yurugi, Chen, Fengshi, Fujinaga, Takuji, Bando, Toru, Fengshi Chen, Taira Maekawa, Toru Bando, Hiroshi Date, Shoji, Tsuyoshi, Date, Hiroshi, Yurugi, Kimiko, Maekawa, Taira   +13 more
core   +1 more source

A Retrospective Study on Neonatal Jaundice: Early Risk Stratification Value of DAT‐FAT Serological Profiles Confirmed by AET

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This retrospective study aimed to explore the value of DAT‐FAT serological profiles confirmed by AET in classifying neonatal jaundice, evaluating its severity, and guiding clinical management. A total of 915 jaundiced newborns (584 pathological, 331 physiological) admitted from July 2018 to August 2021 were included.
Tian‐Ge Wu, Yan‐Feng Zhang, Zhong‐Jun Shen, Yao Li, Ning Xu, Xiao‐Yi Liu, Li‐Yan Zhao, Ming‐Hao Shi   +7 more
wiley   +1 more source

Patient and graft survival rates of ABO-CKT and ABO-IKT before propensity score matching.

, 2018
(a) Patient survival rates (b) Graft survival rates. ABO-CKT; ABO-compatible kidney transplantation, ABO-IKT; ABO-incompatible kidney transplantation.
Tatsuya Nakatani (765860), Tomoaki Iwai (6166697), Takuma Ishihara (3394025), Junji Uchida (488633), Hisao Shimada (6166694), Ayumi Shintani (11873), Kazuya Kabei (6166691), Keiko Maeda (621699), Toshihide Naganuma (6166703), Norihiko Kumada (6166706), Shunji Nishide (6166688), Yoshiaki Takemoto (4706389), Nobuyuki Kuwabara (6166700), Akihiro Kosoku (6166685)   +13 more
core   +1 more source

B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis

Journal of the Formosan Medical Association, 2015
The effect of rituximab on B cell and immunoglobulin production after therapeutic apheresis has not been studied in ABO-incompatible renal transplant patients.
Meng-Kun Tsai, Ming-Shiou Wu, Ching-Yao Yang, Chih-Yuan Lee, Chi-Chuan Yeh, Rey-Heng Hu, Po-Huang Lee, Hong-Shiee Lai   +7 more
doaj   +1 more source

Patient and graft survival rates of ABO-CKT and ABO-IKT after propensity score matching.

, 2018
(a) Patient survival rates (b) Graft survival rates. ABO-CKT; ABO-compatible kidney transplantation, ABO-IKT; ABO-incompatible kidney transplantation.
Tatsuya Nakatani (765860), Tomoaki Iwai (6166697), Takuma Ishihara (3394025), Junji Uchida (488633), Hisao Shimada (6166694), Ayumi Shintani (11873), Kazuya Kabei (6166691), Keiko Maeda (621699), Toshihide Naganuma (6166703), Norihiko Kumada (6166706), Shunji Nishide (6166688), Yoshiaki Takemoto (4706389), Nobuyuki Kuwabara (6166700), Akihiro Kosoku (6166685)   +13 more
core   +1 more source

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study

Transplantation Direct, 2019
Background. The ABO blood-type barrier in kidney and liver transplantation has been overcome by aggressive treatments such as B cell depletion using rituximab.
Daisuke Ueda, MD, Atsushi Yoshizawa, MD, PhD, Masakatsu Kaneshiro, MD, Yoshihiro Hirata, MD, PhD, Shintaro Yagi, MD, PhD, Koichiro Hata, MD, PhD, Hideaki Okajima, MD, PhD, Hiroto Egawa, MD, PhD, Shinji Uemoto, MD, PhD   +8 more
doaj   +1 more source

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation

Frontiers in Medicine, 2020
Pure red cell aplasia (PRCA) after ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT) is caused by persisting host-derived isohemagglutinins directed against donor red blood cell (RBC) antigens.
Ammon Handisurya, Ammon Handisurya, Nina Worel, Werner Rabitsch, Marija Bojic, Sahra Pajenda, Roman Reindl-Schwaighofer, Wolfgang Winnicki, Andreas Vychytil, Hanna A. Knaus, Rainer Oberbauer, Kurt Derfler, Philipp Wohlfarth   +12 more
doaj   +1 more source